A Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605
Clinical trial NCT02916602 · COMPLETED
Trial details
- NCT number
- NCT02916602
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-09-01
- Enrollment
- 340
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.